Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multivesicular body subunit 12A (MVB12A) is a protein component of the ESCRT-I (Endosomal Sorting Complex Required for Transport-I) complex that plays a central role in endosomal sorting and the biogenesis of multivesicular bodies[1][2]. MVB12A enables lipid and ubiquitin binding, and is involved in the regulation of epidermal growth factor receptor (EGFR) signaling by mediating cargo sorting into MVBs prior to lysosomal degradation[1][2]. It is essential for efficient vesicular trafficking, interacts with other ESCRT-I components (such as TSG101, VPS28, and VPS37), and enhances the sorting of endocytic ubiquitinated cargos [1][2]. MVB12A has been associated with diseases involving dysregulation of endosomal trafficking, such as atypical hemolytic-uremic syndrome and viral budding during HIV infection. While not a direct therapeutic target, MVB12A is critical in pathways relevant to cellular signaling and viral pathogenesis[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multivesicular body subunit 12A (MVB12A).